We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

This study has been terminated.
(Regulatory decision not to proceed)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00156962
First Posted: September 12, 2005
Last Update Posted: July 21, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Amgen
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)